{"id":"W1505282125","doi":"10.1002/art.38973","title":"Effect of Certolizumab Pegol Over Ninety‐Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial","year":2014,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; AstraZeneca (Canada)","funders":"UCB Pharma; Celltrion; Genentech; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"BASDAI; Medicine; Certolizumab pegol; BASFI; Ankylosing spondylitis; Placebo; Internal medicine; Physical therapy; Randomized controlled trial; Dosing; Rheumatoid arthritis; Etanercept","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004593335,0.0005874522,0.003756661,0.0003340415,0.0001336818,0.00002291263,0.0001652484,0.0003231229,0.0004796983],"category_scores_gemma":[0.001462008,0.0004619323,0.000396291,0.0003296542,0.0006318102,0.0001558255,0.0001092315,0.0003614648,0.00006546248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000738352,"about_ca_system_score_gemma":0.00009492604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003924259,"about_ca_topic_score_gemma":0.001668358,"domain_scores_codex":[0.9951265,0.000912592,0.001725555,0.0008912421,0.0005786003,0.0007654477],"domain_scores_gemma":[0.9964199,0.001860253,0.0006137556,0.0007024106,0.0001655449,0.0002381124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9218847,0.00160868,0.02373675,0.00004230467,0.0004509391,0.0005044345,0.0005263097,5.532266e-7,0.00001360095,0.0002117075,0.0003697969,0.0506502],"study_design_scores_gemma":[0.9743081,0.01832049,0.003972245,0.001316195,0.0002422634,0.0002822867,0.00003235884,0.00006075497,0.0002404611,0.0001003561,0.0007570183,0.0003674291],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991222,0.00179653,0.00002405422,0.0002278809,0.0007968267,0.003884334,0.0004014977,0.00009301291,0.001553888],"genre_scores_gemma":[0.9972081,0.0008087004,0.0002068681,0.00004417032,0.00008483162,0.0004730852,0.001051992,0.00006953943,0.00005272332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05242342,"threshold_uncertainty_score":0.9997832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004222579586209002,"score_gpt":0.24623893835316,"score_spread":0.242016358766951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}